type III hyperlipoproteinemia
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
metabolic disorder |
| gptkbp:alsoKnownAs |
gptkb:familial_dysbetalipoproteinemia
broad beta disease |
| gptkbp:causedBy |
mutation in APOE gene
|
| gptkbp:characterizedBy |
accumulation of remnant lipoproteins
elevated cholesterol elevated triglycerides |
| gptkbp:diagnosedBy |
genetic testing
lipid profile |
| gptkbp:firstDescribed |
gptkb:Carl_Müller
|
| https://www.w3.org/2000/01/rdf-schema#label |
type III hyperlipoproteinemia
|
| gptkbp:inheritance |
autosomal recessive
|
| gptkbp:MeSH_ID |
D006949
|
| gptkbp:OMIM |
107741
|
| gptkbp:prevalence |
rare
|
| gptkbp:riskFactor |
coronary artery disease
peripheral vascular disease premature atherosclerosis |
| gptkbp:symptom |
gptkb:xanthoma
palmar xanthoma tuberous xanthoma |
| gptkbp:treatment |
gptkb:fibrates
statins diet modification |
| gptkbp:bfsParent |
gptkb:APOE-e2
|
| gptkbp:bfsLayer |
6
|